SUPRIYA

Supriya Lifescience Share Price

₹745.45 +1.55 (0.21%)

20 Apr, 2025 12:20

SIP TrendupStart SIP in SUPRIYA

Start SIP

Performance

  • Low
  • ₹733
  • High
  • ₹759
  • 52 Week Low
  • ₹330
  • 52 Week High
  • ₹842
  • Open Price₹746
  • Previous Close₹744
  • Volume225,046

Investment Returns

  • Over 1 Month + 12.96%
  • Over 3 Month + 7.53%
  • Over 6 Month + 34.29%
  • Over 1 Year + 104.99%
SIP Lightning

Smart Investing Starts Here Start SIP with Supriya Lifescience for Steady Growth!

Invest Now

Supriya Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 34.4
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 6,000
  • P/B Ratio
  • 6.6
  • Average True Range
  • 49.41
  • EPS
  • 21.68
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 15.64
  • RSI
  • 56.4
  • MFI
  • 60.01

Supriya Lifescience Financials

Supriya Lifescience Technicals

EMA & SMA

Current Price
₹745.45
+ 1.55 (0.21%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹711.20
  • 50 Day
  • ₹694.57
  • 100 Day
  • ₹676.80
  • 200 Day
  • ₹617.50

Resistance and Support

745.88 Pivot Speed
  • R3 784.22
  • R2 771.58
  • R1 758.52
  • S1 732.82
  • S2 720.18
  • S3 707.12

What's your outlook on Supriya Lifescience?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Supriya Lifescience is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) with over 38 APIs across various therapeutic segments. It exports to 86 countries, supplying high-quality APIs for pharmaceuticals, nutraceuticals, and personal care industries.

Supriya Lifescience has an operating revenue of Rs. 670.56 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 29% is great, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 20% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -6% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 83 which is a GOOD score indicating consistency in earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Supriya Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-03-10 Others Inter-alia, to consider 1. Appointment of Company Secretary and Compliance Officer of the Company. 2. Other business matters. per share(30%)Final Dividend
2025-01-24 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2024-10-28 Quarterly Results
2024-08-10 Quarterly Results
2024-05-28 Audited Results & Final Dividend

Supriya Lifescience F&O

Supriya Lifescience Shareholding Pattern

68.3%
0.66%
1.7%
7.19%
16.4%
5.75%

About Supriya Lifescience

  • NSE Symbol
  • SUPRIYA
  • BSE Symbol
  • 543434
  • ISIN
  • INE07RO01027

Similar Stocks to Supriya Lifescience

Supriya Lifescience FAQs

Supriya Lifescience share price is ₹745 As on 20 April, 2025 | 12:06

The Market Cap of Supriya Lifescience is ₹5999.6 Cr As on 20 April, 2025 | 12:06

The P/E ratio of Supriya Lifescience is 34.4 As on 20 April, 2025 | 12:06

The PB ratio of Supriya Lifescience is 6.6 As on 20 April, 2025 | 12:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23